Ramifications of Big Pharma Investments and Fiscal Challenges Shake UK
The aftermath of Donald Trump's State Visit continues to reverberate as Britain's top pharmaceutical companies, AstraZeneca and GSK, announced a staggering £59 billion investment commitment in the US over the.....
Subscribe for Full Access!
Gain valuable retail and trade intelligence from our database of millions of data points spanning 20+ years!
